Search Browse Earnings

Caris Life Sciences, Inc. — SlamSEC

Caris Life Sciences, Inc.

Nasdaq:CAI

Services-Medical Laboratories·IRVING, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$306.1M

FY 2025

Adj. EBITDA

-$270.6M

-88.4% margin

FY 2025

Net Income

-$341.4M

-111.5% margin

FY 2025

EPS (Diluted)

-$13.24

FY 2025

Stock Price

$18.68

+0.4%

2026-03-10

52W Range

$17.15 – $42.50

P/E Ratio

-1.4x

Market Cap

$5.3B

Cash

$64.0M

FY 2025

Total Debt

$319.4M

FY 2025

Net Debt

$255.5M

FY 2025

Enterprise Value

$5.5B

Debt / EBITDA

-0.9x

FY 2025

EV / EBITDA

-20.5x

Employees

—